4WHIM: Evaluating the Oral CXCR4 Antagonist Mavorixafor in Patients With WHIM Syndrome via a Global Phase 3, Randomized, Placebo-Controlled Trial With Open-label Extension
JOURNAL OF CLINICAL IMMUNOLOGY（2022）
关键词
primary immunodeficiency, clinical trial, WHIM syndrome, randomized, myelokathexis, neutropenia, CXCR4
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要